Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(3)
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
853.5000
11.30
(
1.34
%)
NSE
Jun 12, 2026
10:12 AM
30.43% Fall from 52W High
Volume:
109.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
21 Jun 2023
853.50
1.34%
NATCO PHARMA
Buy:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 765
Target
Geojit BNP Paribas
ICICI Securities Limited upgraded Natco Pharma Ltd. to Hold with a price target of 1000.0 on 31 May, 2026.
More from Natco Pharma Ltd.
Recommended
Market opens higher, Cyient's board approves a Rs 720 crore buyback
Trendlyne Marketwatch |
12 Jun 2026, 09:41AM
India's cash transfers to women are hurting everyone, including women
The Baseline |
11 Jun 2026, 03:58PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020